Picture of Arcutis Biotherapeutics logo

ARQT Arcutis Biotherapeutics Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapNeutral

Annual cashflow statement for Arcutis Biotherapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

2017
December 31st
2018
December 31st
2019
December 31st
2020
December 31st
2021
December 31st
Period Length:12 M12 M12 M12 M12 M
Source:PROSPECTUSPROSPECTUS10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line-4.98-19.3-42-136-206
Depreciation
Non-Cash Items0.9243.060.5978.3927.7
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.2792.11-1.514.13.62
Change in Prepaid Expenses
Change in Other Assets
Change in Accounts Payable
Change in Accrued Expenses
Cash from Operating Activities-3.77-14.1-42.8-113-175
Capital Expenditures-0.295-0.321-0.995
Purchase of Fixed Assets
Other Investing Cash Flow Items0-11.5-26-182-75
Sale/Maturity of Investment
Purchase of Investments
Cash from Investing Activities0-11.5-26.3-182-76
Financing Cash Flow Items-1.40-1.64
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities7.1261.693.1298282
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash3.343623.93.2931.4

Or unlock with your email

Or unlock with your email